Navidea Biopharmaceuticals CEO Michael Goldberg's 2018 pay jumps 76% to $1.5M
Navidea Biopharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: June 28, 2019
Navidea Biopharmaceuticals reported fiscal year 2018 executive compensation information on June 28, 2019.
In 2018, five executives at Navidea Biopharmaceuticals received on average a compensation package of $541K, a 21% decrease compared to previous year.
Average pay of disclosed executives at Navidea Biopharmaceuticals
Michael M. Goldberg, Chief Executive Officer, received $1.5M in total, which increased by 76% compared to 2017.
Jed A. Latkin, Chief Executive Officer, received a compensation package of $640K, which decreased by 21% compared to previous year. 57% of the compensation package, or $363K, was in salary.
Joel H. Kaufman, Chief Business Officer, earned $313K in 2018.
Frederick O. Cope, Chief Scientific Officer, received $248K in 2018, which decreases by 35% compared to 2017.
Michael S. Rosol, Chief Medical Officer, earned $11K in 2018.
Related executives
Jed Latkin
Navidea Biopharmaceuticals
Chief Executive Officer
Michael Goldberg
Navidea Biopharmaceuticals
Chief Executive Officer
Frederick Cope
Navidea Biopharmaceuticals
Chief Scientific Officer
Michael Rosol
Navidea Biopharmaceuticals
Chief Medical Officer
Joel Kaufman
Navidea Biopharmaceuticals
Former Chief Business Officer
You may also like
Source: SEC filing on June 28, 2019.